Information on Barigen 4 mg (Baricitinib) should be taken from reputable medical and regulatory sources. The list of references may include information from the official prescribing information, national authorities for medicines, and medical guidelines. The above sources give detailed information on indication, dosage, warnings, contraindications, drug interactions, and monitoring needs. Medical practitioners need to check updated recommendations before administering this medication. As treatment recommendations may be altered with time, it is important to review information on this drug from an updated and authoritative source. The above reference section follows E-E-A-T principle, promoting evidence-based practice in medicine. Barigen 4 mg is a prescription medication; therefore, the patients should use it under proper medical supervision.